Difference between revisions of "Pharm Tech Minutes 2019.04.11"
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
Michael tan (talk | contribs) |
||
| Line 46: | Line 46: | ||
== 9:35 - 10:30 Work-item "Adverse Event Reporting (ADER)" Part 1 == | == 9:35 - 10:30 Work-item "Adverse Event Reporting (ADER)" Part 1 == | ||
| − | * | + | * Funding has not been succesful. Lareb has sent in a pitch, but the Dutch government did not reward it with a funding. |
| − | * | + | * EMA has their focus on IDMP and look at the IHE proposal as a responsibility of each country. |
| − | * | + | * We should continue to look for funding for example through Universities and or European funding. |
| − | + | * Try to get HL7 Europe interested ( Catherine Chronaki). | |
| − | + | * Some countries are already experimenting with adverse events for example [https://developer.nhs.uk/apis/itk3tocedischarge-2-5-0/explore_allergies_and_adverse_reactions.html| UKproject] | |
| + | * The FHIR resource itself is not mature ( level 0). The Patient Care workgroup have a biweekly telephone conference on Thursday's 5 pm EST on this topic. | ||
| + | * IHE Pharmacy will continue to pursue to find interested parties and for funding of this project. | ||
| + | * The Adverse Event and Edverse Event reporting are tightly related and are important for the pharmaco vigilance. | ||
== 10:30 - 11:00 --- Coffee break --- == | == 10:30 - 11:00 --- Coffee break --- == | ||
Revision as of 03:16, 11 April 2019
Meeting minutes
WebEx details:
Join IHE Pharmacy's WebEx meeting
Wed., April 10th at Thurs., April 11th, 2019, 9:00.... | 9 am
Paris (Europe Summer GMT + 02: 00)
Organizer: Conferentiefaciliteit
Meeting Number: 234 934 563
Password : This meeting is not protected by a password.
audio connection
+ 44-203-478-5289 UK Domestic Toll
Access code: 234 934 563
You need numbers or additional information? See international phone numbers .
Minutes
09:30 - 09:35 Welcome
- Participants
- Stephane Spahni
- Esther Peelen
- Jacqueline Surugue
- Michael Tan
- Marc Robberecht
- Jose Costa Teixeira
- Leonidas Tzimis
9:35 - 10:30 Work-item "Adverse Event Reporting (ADER)" Part 1
- Funding has not been succesful. Lareb has sent in a pitch, but the Dutch government did not reward it with a funding.
- EMA has their focus on IDMP and look at the IHE proposal as a responsibility of each country.
- We should continue to look for funding for example through Universities and or European funding.
- Try to get HL7 Europe interested ( Catherine Chronaki).
- Some countries are already experimenting with adverse events for example UKproject
- The FHIR resource itself is not mature ( level 0). The Patient Care workgroup have a biweekly telephone conference on Thursday's 5 pm EST on this topic.
- IHE Pharmacy will continue to pursue to find interested parties and for funding of this project.
- The Adverse Event and Edverse Event reporting are tightly related and are important for the pharmaco vigilance.
10:30 - 11:00 --- Coffee break ---
11:00 - 12:30 Medication Information Sharing
- Strategic discussion on IDMP, Medication knowledge and supporting HL7 resources
- International Board asked us to think about IDMP
- Understanding the influence of IDMP
- EU Horizon 2020 project: "Upscaling the global identification of medicines"
12:30 - 13:00 --- Lunch ---
13:00 - 15:15 Supply topics Part 1
- Review current status
- Define work items, schedule and next steps
- Scope
- Priorities
- Work-item members
- Plans and strategies on uptake
15:15 - 15:45 --- Coffee break ---
15:45 - 16:45 Supply topics Part 2
- Continue work
- Work on Technical Supplement